News & Events
If there was a way to catch Alzheimer's earlier, to see its onset in the most nascent of stages, medical researchers postulate that would allow patients to access novel treatments earlier than ever before. At the University of Minnesota's Center for Drug Design (CDD), researchers are working towards that goal. First, however, the must surmount the problem of early detection. Read the article by John Tolley (and watch the video): Here
Finding a viable treatment for Alzheimer’s disease (AD) continues to frustrate researchers around the world. The University of Minnesota Center for Drug Design’s Robert Vince, PhD, and Swati More, PhD, aren’t exempt. Profs. Vince, More, and their colleagues are developing a drug to treat early AD, but they wanted a faster way to test whether their compound was working.
The University of Minnesota Twin Cities and Windgap Medical have received a $3.2 million grant from the National Institutes of Health (NIH) to develop a new device to quickly administer a recently developed antidote for cyanide poisoning. Read the article: Click Here
NBC/KARE 11 News: Eye Exam to Detect Alzheimer's
Read the full story and watch the video by Heidi Wigdahl: Click Here
Camera at U of M may help researchers detect early signs of Alzheimer's.
Prof Christine Salomon's lecture 'Tales from the underground: Searching for biocontrol treatments for white nose syndrome in bats' drew a big crowd at University of North Carolina.
Center for Drug Design (College of Pharmacy, University of Minnesota) has signed an agreement to collaborate with medical imaging startup RetiSpec to commercialize the technology for early detection of Alzheimer’s disease. Read More